HIVE(HIVE)
HIVE
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $400M | $499M |
| Low | $343M | $448M |
| High | $447M | $553M |
| EBITDA Avg | $115M | $143M |
| Low | $99M | $129M |
| High | $128M | $159M |
| EBIT Avg | $-87M | $-108M |
| Low | $-97M | $-120M |
| High | $-75M | $-97M |
| Net Income Avg | $-158M | $-103M |
| Low | $-176M | $-118M |
| High | $-140M | $-90M |
| EPS Avg | $-0.70 | $-0.46 |
| Low | $-0.78 | $-0.52 |
| High | $-0.62 | $-0.40 |
| Analysts (Rev / EPS) | 4 / 2 | 3 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $91M | $107M | $119M | $119M | $119M | $127M | $134M |
| Low | $78M | $93M | $103M | $104M | $103M | $110M | $117M |
| High | $98M | $122M | $135M | $136M | $136M | $144M | $153M |
| EBITDA Avg | $26M | $31M | $34M | $34M | $34M | $36M | $39M |
| Low | $22M | $27M | $30M | $30M | $30M | $32M | $33M |
| High | $28M | $35M | $39M | $39M | $39M | $41M | $44M |
| EBIT Avg | $-20M | $-23M | $-26M | $-26M | $-26M | $-27M | $-29M |
| Low | $-21M | $-27M | $-29M | $-29M | $-29M | $-31M | $-33M |
| High | $-17M | $-20M | $-22M | $-22M | $-22M | $-24M | $-25M |
| Net Income Avg | $-42M | $-37M | $-35M | $-27M | $-24M | $-23M | $-21M |
| Low | $-46M | $-44M | $-41M | $-32M | $-28M | $-27M | $-25M |
| High | $-38M | $-31M | $-29M | $-23M | $-20M | $-19M | $-17M |
| EPS Avg | $-0.19 | $-0.17 | $-0.15 | $-0.12 | $-0.11 | $-0.10 | $-0.09 |
| Low | $-0.21 | $-0.20 | $-0.18 | $-0.14 | $-0.13 | $-0.12 | $-0.11 |
| High | $-0.17 | $-0.14 | $-0.13 | $-0.10 | $-0.09 | $-0.08 | $-0.08 |
| Analysts (Rev / EPS) | 5 / 5 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 | 1 / 2 |